Ticker: TARA

Protara Therapeutics, Inc. (NASDAQ: TARA) Quick read - what's happening inside: The company is ramping clinical activity across two lead programs (TARA‑002 in NMIBC and LMs; IV Choline Chloride for parenteral support), increasing R&D spend and advancing THRIVE‑3 and ADVANCED‑2 milestones. Managem...

Protara Therapeutics, Inc. (NASDAQ: TARA), is a clinical-stage biopharmaceutical company focusing on innovative therapies for cancer and rare diseases. Key highlights from their recent financial performance and operations are summarized below. Financial Highlights (Three Months Ended March 31, 20...